Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1970 1
1980 2
1981 1
1983 2
1986 5
1987 9
1988 55
1989 152
1990 184
1991 159
1992 200
1993 197
1994 240
1995 205
1996 228
1997 222
1998 207
1999 226
2000 215
2001 227
2002 291
2003 281
2004 247
2005 285
2006 256
2007 253
2008 305
2009 366
2010 390
2011 397
2012 408
2013 427
2014 465
2015 441
2016 459
2017 498
2018 511
2019 527
2020 554
2021 572
2022 411
2023 391
2024 161

Text availability

Article attribute

Article type

Publication date

Search Results

10,378 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Precursor lymphoblastic lymphoma/leukemia"
Page 1
Acute lymphoblastic leukaemia.
Malard F, Mohty M. Malard F, et al. Lancet. 2020 Apr 4;395(10230):1146-1162. doi: 10.1016/S0140-6736(19)33018-1. Lancet. 2020. PMID: 32247396 Review.
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...However, the outcome of older adults (40 years) and patients with relapsed or refractory acute lymphoblastic leukaemia remains poor …
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence between 1 year and 4 years. ...Howev …
Update on Lymphoblastic Leukemia/Lymphoma.
Luca DC. Luca DC. Clin Lab Med. 2021 Sep;41(3):405-416. doi: 10.1016/j.cll.2021.04.003. Clin Lab Med. 2021. PMID: 34304772 Review.
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias; however, they are also encountered with significant frequency in the adult population. These neoplastic processes can be of B-cell …
Lymphoblastic leukemias/lymphomas are predominantly diseases of childhood, where they represent almost all acute leukemias …
Acute lymphoblastic leukemia.
Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili N. Chang JH, et al. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28371. doi: 10.1002/pbc.28371. Pediatr Blood Cancer. 2021. PMID: 33818880 Review.
The survival of patients with acute lymphoblastic leukemia (ALL) has improved significantly with the use of intensive multimodality treatment regimens including chemotherapy, high-dose chemotherapy and stem cell rescue, and radiation therapy when indicated. . …
The survival of patients with acute lymphoblastic leukemia (ALL) has improved significantly with the use of intensive multimod …
Acute Lymphoblastic Leukemia in Children.
Hunger SP, Mullighan CG. Hunger SP, et al. N Engl J Med. 2015 Oct 15;373(16):1541-52. doi: 10.1056/NEJMra1400972. N Engl J Med. 2015. PMID: 26465987 Review. No abstract available.
Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T, Weber A, Leoncin M, Frison L, Skert C, Bassan R. Intermesoli T, et al. Curr Oncol Rep. 2022 Jan;24(1):1-12. doi: 10.1007/s11912-021-01168-x. Epub 2022 Jan 20. Curr Oncol Rep. 2022. PMID: 35059993 Review.
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually indistinguishable from acute lymphoblastic leukemia (ALL). ...Positron-emission tomography, genetic risk classifications, and min …
PURPOSE OF REVIEW: Lymphoblastic lymphoma (LBL) is a rare, highly aggressive non-Hodgkin lymphoma variant virtually ind …
Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
Burkhardt B, Hermiston ML. Burkhardt B, et al. Br J Haematol. 2019 Jun;185(6):1158-1170. doi: 10.1111/bjh.15793. Epub 2019 Feb 27. Br J Haematol. 2019. PMID: 30809797 Free article. Review.
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adolescence, accounting for 25-35% of all cases. The majority, 70-80%, is of T-lymphoblastic origin while 20-25% arise from B lymphoblasts. With …
Lymphoblastic lymphoma (LBL) is the second most common type of Non-Hodgkin Lymphoma (NHL) in childhood and adolescence, …
How I treat newly diagnosed and refractory T-cell acute lymphoblastic lymphoma in children and young adults.
Si Lim SJ, Ford JB, Hermiston ML. Si Lim SJ, et al. Blood. 2023 Jun 22;141(25):3019-3030. doi: 10.1182/blood.2022016503. Blood. 2023. PMID: 37018730
T-cell lymphoblastic lymphoma (T-LLy) and T-cell acute lymphoblastic leukemia (T-ALL) have historically been considered a spectrum of the same disease. ...We discuss results of recent clinical trials incorporating use of nelarabine and bo …
T-cell lymphoblastic lymphoma (T-LLy) and T-cell acute lymphoblastic leukemia (T-ALL) have histori …
Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Abou Dalle I, Jabbour E, Short NJ, Ravandi F. Abou Dalle I, et al. Curr Treat Options Oncol. 2019 Jan 24;20(1):4. doi: 10.1007/s11864-019-0603-z. Curr Treat Options Oncol. 2019. PMID: 30675645 Free PMC article. Review.
With the introduction of tyrosine kinase inhibitors (TKIs) in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), the prognosis of patients has improved dramatically. ...Clinicians should be aware of possible fatal cardi …
With the introduction of tyrosine kinase inhibitors (TKIs) in the management of Philadelphia chromosome-positive acute lymphoblastic …
Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
Peters JM, Ansari MQ. Peters JM, et al. Arch Pathol Lab Med. 2011 Jan;135(1):44-54. doi: 10.5858/2010-0387-RAR.1. Arch Pathol Lab Med. 2011. PMID: 21204710 Free article. Review.
CONTEXT: Timely and accurate diagnosis of hematologic malignancies is crucial to appropriate clinical management. Acute leukemias are a diverse group of malignancies with a range of clinical presentations, prognoses, and preferred treatment protocols. ...CONCLUSION: …
CONTEXT: Timely and accurate diagnosis of hematologic malignancies is crucial to appropriate clinical management. Acute leukemias are …
Lymphoblastic lymphoma.
Cortelazzo S, Ferreri A, Hoelzer D, Ponzoni M. Cortelazzo S, et al. Crit Rev Oncol Hematol. 2017 May;113:304-317. doi: 10.1016/j.critrevonc.2017.03.020. Epub 2017 Mar 18. Crit Rev Oncol Hematol. 2017. PMID: 28427520 Review.
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) that accounts for approximately 2% of all lymphomas. Although histological features are usually sufficient to distinguish lymphoblastic …
Lymphoblastic lymphoma (LBL) is a neoplasm of immature B cells committed to the B-(B-LBL) or T-cell lineage (T-LBL) tha …
10,378 results
You have reached the last available page of results. Please see the User Guide for more information.